|Bid||1.610 x 800|
|Ask||1.620 x 1800|
|Day's Range||1.550 - 1.630|
|52 Week Range||1.540 - 14.580|
|PE Ratio (TTM)||N/A|
|Earnings Date||Jun 4, 2018 - Jun 8, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||4.00|
Fred’s Inc. (“Fred’s” or “Company”) (FRED) today announced that Dana Goldsmith Needleman and Thomas Zacharias have been appointed to the Company’s Board of Directors, effective May 20, 2018. The appointments are in connection with the retirement of Mike McMillan, Peter Bocian and Neeli Bendapudi. Ms. Goldsmith Needleman has been serving as a principal of The Cogent Group, a private real estate investment firm, since 2009.
NEW YORK, May 14, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Fred's, ...
On May 7, Fred’s (FRED) said that CVS Health (CVS) has agreed to purchase some of the assets of its specialty pharmacy business, EntrustRx, for $40 million. Fred’s has been looking to turn around its financials by reducing debt and generating positive earnings and free cash flow. CVS is among leading US providers of specialty pharmacy services.
Buildings are reflected in the window of a CVS Health Corp. store in downtown Los Angeles, California, U.S., on Friday, Oct. 27, 2017. Fred’s Inc. said CVS Health is buying its specialty pharmacy business EntrustRx for $40 million amid the retailer’s effort to execute a financial turnaround. “One of Fred’s top priorities for 2018 has been to monetize non-core assets and we are pleased to have reached an agreement for the sale of EntrustRx,” Fred’s interim CEO Joseph Anto said in a statement Monday afternoon.
Fred's, Inc. (FRED) announced that it has reached a definitive agreement to sell certain assets of EntrustRx, its specialty pharmacy unit, to a subsidiary of CVS Health Corporation (CVS). Fred’s was advised on this transaction by Covington Associates and by Bass Berry & Sims. Tracing its history back to an original store in Coldwater, Mississippi, opened in 1947, today Fred’s, Inc. operates approximately 600 general merchandise and pharmacy stores, including 12 franchised locations, and three specialty pharmacy-only locations.
Fred's Pharmacy on Friday, May 4, 2018 said planned to sell its specialty pharmacy business and look at various options for its retail pharmacies. Fred’s confirmed Friday plans to sell the company’s specialty pharmacy business as part of a turnaround plan. Potential bidders could include larger pharmacy chains CVS Health, Walgreens Boots Alliance, and Rite Aid that are already reporting specialty pharmacy as a key driver of overall growth as more patients need help with management and related support for the complex medications they take for their chronic and sometimes rare conditions.
Fred's Inc. is evaluating options for its retail pharmacy portfolio. Fred’s is evaluating options for its retail pharmacy portfolio and “actively pursuing a sale” of its specialty pharmacy business, the retailer said Friday, a year after the company failed to buy hundreds of Rite Aids. “Some of the strategic transactions we are actively pursuing include a sale of our specialty pharmacy business and portions of our vast real estate portfolio," Antos added.
The Memphis, Tennessee-based company said it had a loss of 88 cents per share. Losses, adjusted to account for discontinued operations, came to 62 cents per share. The discount retailer posted revenue ...
NEW YORK, NY / ACCESSWIRE / May 4, 2018 / FRED'S, Inc. Class A (NASDAQ: FRED ) will be discussing their earnings results in their Q4 Earnings Call to be held on May 4, 2018 at 8:00 AM Eastern Time. To ...
MEMPHIS, Tenn., May 04, 2018-- Fred's, Inc. reported financial results for the fourth quarter and fiscal year ended February 3, 2018.. Commenting on today’ s announcement, Fred’ s Interim CEO, Joseph Anto ...
Glancy Prongay & Murray LLP announces that it has commenced an investigation on behalf of Fred’s Inc. investors concerning the Company and its officers’ possible violations of federal securities laws.
Law Offices of Howard G. Smith announces an investigation on behalf of Fred’s Inc. investors concerning the Company and its officers’ possible violations of federal securities laws.
Two years ago, the New York-based hedge fund was a nonentity to Fred’s. Today, they are running the company.
Fred's CEO Michael K. Bloom has resigned as CEO after less than two years in the top job and a failed attempt to buy hundreds of Rite Aids.
Fred's Inc, which was forced to abandon its bid to acquire certain stores of drug retailer Rite Aid Corp, said on Friday its Chief Executive Officer Michael Bloom has resigned. The discount store operator said Chief Financial Officer Joseph Anto took over from Bloom as the interim CEO on April 24. In June, Fred's was forced to scrap its bid for 1,200 Rite Aid Corp stores, a deal that was chalked out so that drugstore chain Walgreens Boots Alliance Inc could win antitrust approval for its purchase of Rite Aid.
MEMPHIS, Tenn., April 27, 2018-- Fred’ s Inc. today announced the resignation of Chief Executive Officer Michael K. Bloom, effective as of April 24, 2018, to pursue other opportunities. Joseph Anto, the ...
Fred’s Inc (NASDAQ:FRED), a multiline retail company based in United States, saw a significant share price rise of over 20% in the past couple of months on the NasdaqGS. AsRead More...
Fred's (FRED) has rescheduled its earnings announcement date.This is solely connected to Fred's plans to divest its specialty pharmacy business.